Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Trades today at or near the high. No paint jobs. If one looks at actual trades of significant shares this was a real move up.
db
This is a serious company with involvement across Africa, and intimate connections in many African countries. They have shown time and again that they are a part of the upstream development in oil and gas. Despite the grudge based denigration, their business model has and is working. ERHE has a very bright future.
db
He also forgot to mention when he went to the company with his questionable pocket full of share holders for a seat on the board and was told he was not needed.
And of course that has not colored his opinion. Completely unbiased.
db
Paint.
The bulk of trades were at .04-.041. The few bumps were money market paint.
db
Some people just make stuff up. Some are even motivated enough to defend their fictions.
db
From the ERHE PR:
The farm-out agreement is subject to the consent of the government of the Republic of Kenya.
Under terms of the agreement, ERHC would transfer of a portion of its interest in Kenya Block 11A as well as operatorship.
The proposed farm-out agreement includes a carry and other considerations.
----------------------------
Is it possible if not likely, since our interest is carried by the operator, that portions of our share we dole out are also carried by the operator. Hopefully not just wishful thinking, but it does seem logical to me. We have a carried percent, we give part of it to another party in payment, it remains carried.
db
And that was because of the VALUE of the assets. The company had little but the assets, like now.
db
Yup, me too.
I think the third party is our LOI partner. The release used "third party" to avoid naming our new partner, per the agreement, pending the OK by Kenya.
db
My impression is Anatabine fits the requirements for fast track:
From the FDA:
Any drug being developed to treat or prevent a condition with no current therapy obviously is directed at an unmet need. If there are available therapies, a fast track drug must show some advantage over available therapy, such as:
Showing superior effectiveness, effect on serious outcomes or
improved effect on serious outcomes
Avoiding serious side effects of an available therapy
Improving the diagnosis of a serious condition where early diagnosis results in an improved outcome
Decreasing a clinically significant toxicity of an available therapy that is common and causes discontinuation of treatment
Ability to address emerging or anticipated public health need
http://www.fda.gov/forconsumers/byaudience/forpatientadvocates/speedingaccesstoimportantnewtherapies/ucm128291.htm
As I read it, any one of these may qualify a drug. Anatabine seems to fit on several counts.
db
Lief,
The science trickles in. Like you I think anatabine will eventually be used for many of the auto immune diseases, which affect well over half of the aging population. The possible benefit to public health is staggering. On the order of basics like clean water and sewers.
Still a long long way from the wide spread understanding at a level that would put in the standard of care.
Hopefully this company will keep a big piece of it. Either way many will in all likely hood live longer healthier lives.
Strategically, I don't have a clue as to what is the best approach for STSI, but I am glad the neutraceutical is available. Thousands are benefiting now, including myself.
db
Yes.
There is a reason serious news agencies like Bloomberg and others don't carry releases from Seeking Alpha. No problem for Yahoo. Anything goes. Seeking Alpha disclaims all of it's releases as the author's opinion only to protect itself from lawsuits.
The only reason to sell this stock, and it is a good one, is if you think you can do better with another one or cash. Whether you are after diversification, risk reduction, gain, whatever. Ownership is kept if the stock still meets your goals. Anything else is just not very smart. All the chatter is just chatter.
Ownership is its own answer, and we all know it.
db
Two years is probably a little short.
db
The dollar is the dominant currency in international trade, and all over Europe as well as most of the rest of the world the notation is standard when quoting dollar amounts. I speak some French, Spanish and English. All use the correct notation when quoting dollars.
But thanks for your concern.
Learn where to put the decimal and the dollar sign. Then maybe I'll have a clue as to what you mean.
Your talk of a selling opportunity says you think the price will go up. Any chance you are a little off?
I think there is a good chance you are a bit off.
db
Has the ability to take a bad idea further than anyone would think possible.
db
And Ray Leonard's market cap is in the toilet, with maybe a 20% chance of hitting it big or going bust. No oil, they give up most of what they have for a second shot. And that negotiation will be from an extremely weak position. I like Ray Leonard, but he can't fix a dry hole. Neither could Peter.
Lots of chat liners bad mouthing Ray, just like here. Both companies have a chance to hit it big. Or not.
db
Lots of aging golfers read IBD. Most people over 50 that play any sport will tell about their soreness, aches and pains. IMO that is an add targeted at the perfect population. People (like me) who would benefit from Anatabloc and who are also potential investors.
db
Who is AF?
db
Simply not true. He pretty much brokered the JDZ, got a full carry and 50 million dollars for ERHE, put himself in a position to be one of the richest men in the world. Got Sinopec to spend hundreds of millions on drilling.
I seem to remember you visiting our little company with your suggestions and being rather rudely brushed off. Does give me an opinion of your motivations.
db
Current market cap is 35 million and they need 35 million. I don't see how they get there without more than doubling the number of shares or giving up control to a buyer. And I don't see new shares sold at even current market prices.
db
And overall it is not a bad article. Also the first time I read it on Sunday It had an Anatabloc add at the bottom, lol.
db
Aha! There must be something wrong with me. I love California.
db
What the SEC should be doing is going after naked shorts and manipulators, big and small.
I tend to agree, my guess is NJ's eye changes are coincidental. One small correction, astigmatism is usually caused by the cornea, and corneal curvature is usually measured now by autorefractor/keratometers at the beginning of most eye exams.
You mentioned inflammation in eye problems. One of the most common is ocular surface disease, a catch all term for different kinds of tear film problems. Dry Eye, Blepharitis etc. All of these have an inflammatory component, and I know of two people taking AB for other reasons that have experienced relief from long standing Dry Eye Syndrome. I think this is one more category where eventually AB will be used. By the way, Ocular Surface disease is the most common complaint among older people seeking eye care, and I suspect many AB users are unaware that this problem has improved because of AB.
db
"They generally believe that it was a method for SEO to legally and without controversy increase his ownership stake."
I think they are correct. If one likes this investment, he had better be OK with SEO owning more, regardless of SEO's motivation, because that is exactly what is going to happen.
db
" Why would Offer want to buy at $.075, when he could buy twice as much at $.0375 if he lets this rights offering tank?"
Seriously?
And from brand new poster?
Perhaps you should take a look at company history. As to reasons that won't happen concentrate on the SEC and investor law suits.
db
"Earlier this week, Chrome Oil Services Ltd. and Chrome Energy LLC, which beneficially own approximately 43 percent of ERHC Energy's outstanding common stock, announced their support for ERHC's shareholder proposal."
IMPLIES they will buy, but no promise of full participation. I think they will, but they have NOT said they will.
db
Offer said he supports the financing effort, IMPLYING he and Chrome will participate, and I think he/they will. But he has not promised that will happen. To me the recent availability of shares below the offering price is troubling. Offer wants the next phase of exploration funded, it is a must for the future of ERHE. But if the share price tanks because of worries about the increased number of shares or whatever, there is no firm commitment for Offer/Chrome to participate fully or at all, especially above the market.
Actually having a commitment at .075 would be more comforting for sure. The wording of that announcement leaves a way out if things change. I don't think things will change, and I don't think the share price will drop much from here, but if it does, Chrome and Offer may decide there is another way forward that will give them a larger share of the company. I think his interests come before ours. One way or another I think he/they will rescue ERHE, but at what cost?
The risks here are not insignificant. Place your bets.
My opinion, which may as always be wrong.
db
I disagree. I think he and Chrome will fully subscribe, which will give him/them at least their current percentage ownership. I also think they will pick up any shares not subscribed by other share holders. I doubt seriously that ALL stock holders will fully subscribe, and that will increase their ownership proportionally.
That said, I also believe this is the best way forward. No cash raise means little chance of new asset development by ERHE. Some carries may be in our future, but I doubt very much there will be enough excitement to provide the kind of carry we have in the JDZ.
As to whom to thank, I will thank the SEC. There are many ways in which Chrome/Offer could raise funds and increase their ownership that would not be as beneficial to shareholders. My guess is this course was chosen because it passes the smell test. Pardon my cynicism.
Offer already has effective control. After this I think there will be no doubt. I would rather he had a smaller interest, but I still think this is the best course given the cash situation and the assets acquired.
Further, I won't be subscribing. I will wait and buy in the open market if I want more. The prices are just too close to for me.
I am limited to one post a day so I won't be posting again until tomorrow at least.
Luck to all,
db
Or....
You have to come up with two and a half cents per current share owned to keep your percentage ownership the same as it is now. With all the other factors it will be interesting to see how the share price reacts in the next few weeks.
db
You could reality base the front of that curve for application here with the recent drop in price. Just a thought.
And you can define dilution any way you want, but we are going to have many more shares at a lower price however you define it. That means current share holders will at least initially lose money on paper. That is why the share price is slipping, plain and simple.
Lots of lipstick being applied here. Maybe Kenya will save us, we will see.
db
Yes, his article makes sense, but lundell himself is a non issue. The medical evidence for inflammation as a factor in heart disease is overwhelming.
db
Despite all the speculation, and everything that the company has said, we still have no idea how many shares will be issued and at what price. We have rights to hopeful properties, but we really don't know how much we have to pay to keep our individual percentages. My guess is any discount to the share price will be immediately realized in the market place. Chrome will own more, and we don't know how much more.
All the supportive posts here are based on assumptions.
When we know more the price will be higher? Maybe, but maybe it will be lower.
I'll wait. And that is what the market is doing.
db
Ha ha,
Lower highs and lower lows? Is that your point?
db
The very best thing about the revised press release is that AB continues to verify what many of us think is true. IE that this drug works in humans. Mouse studies are cheap and very interesting, often, as in the case of AB, giving leads for further research, but the Biotech industry is littered with animal studies that don't translate to humans. This one is translating. Huge.
If the final data from Flint is this good, and the thyroid studies are positive, particularly the one with John's Hopkins name on it, the Medical community will start to take notice.
For those with personal experience with AB who understand these studies are likely to be successful, the slow market recognition provides opportunity.
db
The price will go down certainly, proportional to the offering size is my guess. If one likes Offer's control this will bring happiness. As Chrome(Offer)has already said they will participate, and some current stock holders will not, his ownership percentage will increase. No question.
How much? Remains to be seen. He already has effective control, maybe it won't be significantly different.
db